Keming Yu Selected Research

Keming Yu Research Topics

Disease

9	Neoplasms (Cancer) 11/2022 - 09/2012
9	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 07/2013
6	Myopia 07/2023 - 07/2013
5	Glaucoma 10/2022 - 03/2009
4	Ganglion Cysts (Ganglion) 01/2023 - 01/2019
4	Corneal Neovascularization 01/2023 - 01/2014
4	Hypoxia (Hypoxemia) 01/2023 - 07/2007
4	Glioma (Gliomas) 01/2015 - 09/2012
3	Keratoconus 03/2024 - 01/2022
3	Astigmatism 12/2023 - 03/2019
3	Dry Eye Syndromes (Dry Eye Syndrome) 06/2023 - 01/2016
3	Burns 01/2019 - 01/2014
2	Inflammation (Inflammations) 01/2023 - 08/2020
2	Reperfusion Injury 01/2017 - 11/2016
2	Wounds and Injuries (Trauma) 01/2015 - 01/2014
1	Severe Acute Respiratory Syndrome 05/2024
1	COVID-19 05/2024
1	Cysts 12/2023
1	Retinal Neovascularization 01/2023
1	Pathologic Neovascularization 01/2023
1	Papilledema 01/2023
1	Uveitis 01/2023
1	Hypertension (High Blood Pressure) 01/2020
1	Ocular Hypertension (Glaucoma, Suspect) 10/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2019
1	Corneal Opacity 01/2019
1	Neoplasm Metastasis (Metastasis) 05/2017
1	Pathologic Processes 01/2017
1	Retinal Diseases 01/2017
1	Ischemia 11/2016
1	Blister (Bulla) 10/2015
1	Cicatrix (Scar) 10/2015
1	Lung Diseases (Lung Disease) 01/2014
1	Neovascular Glaucoma 01/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2014
1	Genomic Instability 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Thrombosis (Thrombus) 01/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2013

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 07/2023 - 07/2007
9	tetramethylpyrazineIBA 08/2020 - 09/2012
7	Thymidine Monophosphate (TMP)IBA 08/2020 - 08/2013
4	Chemokine ReceptorsIBA 01/2023 - 09/2012
4	plerixafor FDA Link 06/2022 - 09/2012
3	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2021
3	CytokinesIBA 01/2023 - 01/2015
3	AlkaliesIBA 01/2019 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2013
2	EndotoxinsIBA 01/2023 - 08/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2017 - 01/2017
1	Interleukin-6 (Interleukin 6)IBA 05/2024
1	LipidsIBA 03/2024
1	Competitive Endogenous RNAIBA 01/2023
1	HCEIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2022
1	AmarisIBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 08/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	CholesterolIBA 01/2020
1	GATIBA 10/2019
1	Ophthalmic Solutions (Eye Drops)IBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Neuroprotective AgentsIBA 05/2017
1	CXC ChemokinesIBA 05/2017
1	LuciferasesIBA 01/2017
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Ligases (Synthetase)IBA 11/2016
1	LithiumIBA 11/2016
1	Thrombospondin 1IBA 02/2016
1	Protein Isoforms (Isoforms)IBA 10/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	SteroidsIBA 01/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2014
1	Ranibizumab (Lucentis)FDA Link 01/2014
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2013

Therapy/Procedure

5	Lasers (Laser) 07/2022 - 01/2016
5	Laser In Situ Keratomileusis (LASIK) 07/2022 - 07/2013
4	Therapeutics 01/2022 - 02/2016
3	Refractive Surgical Procedures 05/2024 - 01/2021
2	Meridians (Jing Luo) 12/2023 - 04/2021
1	Intraperitoneal Injections 01/2023
1	Immunotherapy 01/2023
1	Excimer Lasers 02/2022
1	Contact Lenses 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Slit Lamp 01/2018
1	Drug Therapy (Chemotherapy) 05/2017
1	Radiotherapy 05/2017
1	Cryotherapy (Therapy, Cold) 05/2017
1	Filtering Surgery 10/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2015
1	Intravitreal Injections 01/2014
1	Trabeculectomy (Trabeculoplasty) 01/2014
1	Light Coagulation 01/2014